APA (7th ed.) Citation

K, R., S, A., E, K., & CL, F. (2025). Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid. JAAD case reports, 65, 201. https://doi.org/10.1016/j.jdcr.2025.08.001

Chicago Style (17th ed.) Citation

K, Ratnarajah, Arès S, Kechichian E, and Fernandes CL. "Combination Therapy Including Dupilumab, Omalizumab, and Mycophenolate Mofetil for Refractory Bullous Pemphigoid." JAAD Case Reports 65 (2025): 201. https://doi.org/10.1016/j.jdcr.2025.08.001.

MLA (9th ed.) Citation

K, Ratnarajah, et al. "Combination Therapy Including Dupilumab, Omalizumab, and Mycophenolate Mofetil for Refractory Bullous Pemphigoid." JAAD Case Reports, vol. 65, 2025, p. 201, https://doi.org/10.1016/j.jdcr.2025.08.001.